VMC
48
-3
NKE
36
-3
SLG
55
-4
PSX
35
-5
CAT
58
-4
DLTR
54
3
WHR
72
-4
LLY
48
-3
ROK
51
-3
MAT
41
-2
CMI
60
-4
DTE
49
2
EXPD
50
7
SPG
51
-5
ROST
68
-2
NUE
47
-4
AME
59
-3
LRCX
59
-5
AMT
37
-8
SCHW
64
3
VMC
48
-3
NKE
36
-3
SLG
55
-4
PSX
35
-5
CAT
58
-4
DLTR
54
3
WHR
72
-4
LLY
48
-3
ROK
51
-3
MAT
41
-2
CMI
60
-4
DTE
49
2
EXPD
50
7
SPG
51
-5
ROST
68
-2
NUE
47
-4
AME
59
-3
LRCX
59
-5
AMT
37
-8
SCHW
64
3
Financhill
Back

Reckitt Benckiser Group PLC Vs. Aligos Therapeutics Industry Stock Comparison

Sell
33

RBGLY
Reckitt Benckiser Group PLC

Last Price:
12.34
Seasonality Move:
-0.28%
Buy
74

ALGS
Aligos Therapeutics

Last Price:
31.58
Seasonality Move:
10.65%
Sell
33
Reckitt Benckiser Group PLC (RBGLY) is a Sell

Is Reckitt Benckiser Group PLC a Buy, Sell or Hold?

  • The current Reckitt Benckiser Group PLC [RBGLY] share price is $12.06. The Score for RBGLY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RBGLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RBGLY Stock Price Chart

What is Reckitt Benckiser Group PLC's stock price today?

  • The Reckitt Benckiser Group PLC share price today is $12.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RBGLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $30.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RBGLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 43.43 Sell
Chaikin Money Flow: 193962 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.07 - 12.47) Sell
Bollinger Bands (100): (11.29 - 12.51) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.32 Buy
Relative Strength Index (14 RSI): 81.62 Buy
Chaikin Money Flow: 315379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.3 - 26.46) Buy
Bollinger Bands (100): (7.85 - 19.03) Buy

RBGLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.22 Sell
20-day SMA: 12.21 Sell
50-day SMA: 12.32 Sell
200-day SMA: 11.68 Buy
8-day EMA: 12.18 Sell
20-day EMA: 12.24 Sell
50-day EMA: 12.21 Sell
200-day EMA: 12.19 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.35 Buy
20-day SMA: 22.81 Buy
50-day SMA: 14.24 Buy
200-day SMA: 15.81 Buy
8-day EMA: 27.13 Buy
20-day EMA: 22.88 Buy
50-day EMA: 17.49 Buy
200-day EMA: 15.94 Buy

Reckitt Benckiser Group PLC Earnings Growth & RBGLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Reckitt Benckiser Group PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):